Evidence map›Paper›PMID 24204770›Full record

ArticlePloS one2013

Zebavidin--an avidin-like protein from zebrafish.

Barbara Taskinen, Joanna Zmurko, Markus Ojanen, Sampo Kukkurainen, Marimuthu Parthiban, Juha A E Määttä, Jenni Leppiniemi, Janne Jänis, Mataleena Parikka, Hannu Turpeinen and 6 more

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Barbara TaskinenInstitute of Biomedical Technology, University of Tampere, BioMediTech, Tampere, Finland ; Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland.
Joanna Zmurko
Markus Ojanen
Sampo Kukkurainen
Marimuthu Parthiban
Juha A E Määttä
Jenni Leppiniemi
Janne Jänis
Mataleena Parikka
Hannu Turpeinen
Mika Rämet
Marko Pesu
Mark S Johnson
Markku S Kulomaa
Tomi T Airenne
Vesa P Hytönen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The avidin protein family members are well known for their high affinity towards D-biotin and high structural stability. These properties make avidins valuable tools for a wide range of biotechnology applications. We have identified a new member of the avidin family in the zebrafish (Danio rerio) genome, hereafter called zebavidin. The protein is highly expressed in the gonads of both male and female zebrafish and in the gills of male fish, but our data suggest that zebavidin is not crucial for the developing embryo. Biophysical and structural characterisation of zebavidin revealed distinct properties not found in any previously characterised avidins. Gel filtration chromatography and native mass spectrometry suggest that the protein forms dimers in the absence of biotin at low ionic strength, but assembles into tetramers upon binding biotin. Ligand binding was analysed using radioactive and fluorescently labelled biotin and isothermal titration calorimetry. Moreover, the crystal structure of zebavidin in complex with biotin was solved at 2.4 Å resolution and unveiled unique ligand binding and subunit interface architectures; the atomic-level details support our physicochemical observations.

Indexed as

GenomeAmino Acid SequenceAnimalsAvidinBiotinCrystallography, X-RayEmbryo, NonmammalianEscherichia coliFemaleFish ProteinsGene ExpressionGillsGlycoproteinsGonadsMaleModels, Molecularavd protein, zebrafishAvidinBiotinFish ProteinsGlycoproteinsProtein IsoformsRecombinant ProteinsZebrafish Proteins

Identifiers

PMID24204770
PMCPMC3811995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.